A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy".
Department of Medicine, University of Pittsburgh, Pennsylvania, USA. vly@pitt.edu
Victor L
VL
Yu
D000942:Antigens, Bacterial / Q000652:urine; D002511:Cephalosporins / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D019095:Point-of-Care Systems; D015363:Quinolones / Q000627:therapeutic use; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification
D000942:Antigens, Bacterial; D002511:Cephalosporins; D010406:Penicillins; D015363:Quinolones